Page 2 - Decipher Prostate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Decipher prostate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Decipher Prostate Today - Breaking & Trending Today

Veracyte, Inc. (NASDAQ:VCYT) Q4 2023 Earnings Call Transcript

Veracyte, Inc. misses on earnings expectations. Reported EPS is $-0.39 EPS, expectations were $-0.07. Veracyte, Inc. ....

United States , William Blair , Marc Stapley , Shayla Gorman , Dustin Scaringe , Ji Nam , Mason Carrico , Rebecca Chambers , Morgan Stanley , Exchange Commission , Research Use , Society Of Urologic Oncology , National Comprehensive Cancer Network , Veracyte Inc , Call Transcript February , Veracyte Fourth Quarter , Full Year , Senior Director , Investor Relations , Chief Executive Officer , Chief Financial , Decipher Prostate , Research Use Only , Urologic Oncology , Veracyte Diagnostics Platform , Global Expansion ,

Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results

Grew Fourth Quarter Revenue to $98.2 million

Increased 2023 Total Revenue 22% to $361.1 million

Conference Call and Webcast Today at 4:30 p.m. ET

. ....

United States , Marc Stapley , Company Form , National Comprehensive Cancer Network , Veracyte Inc , Exchange Commission , Genomics Inc , Veracyte Diagnostics Platform , Decipher Prostate , Percepta Nasal Swab , Regarding Use , Annual Report , Quarterly Report , Decipher Biosciences , Months Ended December , Stockholder Equity , Related Expenses ,

Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results

Veracyte, Inc. today announced financial results for the fourth quarter and full year ended December 31, 2023.

"We closed 2023 with another quarter of excellent results, driven by our Afirma and Decipher businesses," said Marc Stapley, Veracyte's. ....

United States , Marc Stapley , Genomics Inc , Company Form , Veracyte Inc , Exchange Commission , National Comprehensive Cancer Network , Conference Call , Announces Fourth Quarter , Veracyte Diagnostics Platform , Decipher Prostate , Percepta Nasal Swab , Regarding Use , Annual Report , Quarterly Report , Decipher Biosciences , Months Ended December , Stockholder Equity , Related Expenses ,

Veracyte, Inc. (NASDAQ:VCYT) Q3 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Veracyte Third Quarter 2023 Financial Results Webcast. At this time all participants are in a listen-only mode. ....

United States , San Diego , Prashant Kedia , Matt Sykes , Tristan Ribar , Marc Stapley , Phil Febbo , Rebecca Chambers , Goldman Sachs , American Society For Radiation Oncology , Exchange Commission , Scottish Health Technologies Group , Veracyte Inc , American Cancer Society , Call Transcript November , Veracyte Third Quarter , Chief Executive Officer , Chief Financial , Investor Relations , Given Decipher , Decipher Prostate , American Society , Radiation Oncology , Decipher Afirma , Percepta Nasal Swab , Chief Scientific Officer ,

Veracyte, Inc. (NASDAQ:VCYT) Q3 2023 Earnings Call Transcript

Veracyte, Inc. (NASDAQ:VCYT) Q3 2023 Earnings Call Transcript November 7, 2023 Veracyte, Inc. misses on earnings expectations. Reported EPS is $-0.41 EPS, expectations were $-0.16. Operator: Good day, and thank you for standing by. Welcome to the Veracyte Third Quarter 2023 Financial Results Webcast. At this time all participants are in a listen-only mode. [Operator […] ....

United States , Rebecca Chambers , Phil Febbo , Scottish Health Technologies Group , American Cancer Society , Decipher Prostate , Chief Scientific Officer , Chief Medical Officer , Marie Claire Taine , American Dividend Stocks To Buy ,